Biotech, healthcare and health-tech startups, from drug discovery to care delivery. In the last 12 months Value Add VC tracked 96 venture rounds in Health & Biotech totaling $9.1B across 93 companies, with a median round of $66M. The last three months saw 59 rounds and $6.5B, ahead of the 12-month pace.
| Rounds tracked | Last 3 months | Last 6 months | Last 12 months |
|---|---|---|---|
| Rounds | 59 | 90 | 96 |
| Dollars | $6.5B | $8.3B | $9.1B |
| Companies | 58 | 88 | 93 |
| Median round | $75M | $66M | $66M |
Rounds tracked by Value Add VC from filings, wire releases and news outlets, not a total for the whole market. Private companies only.
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Jul 15, 2026 | Neko Health | Series C | $700M | Lightspeed Venture Partners, OG Venture Partners |
| Jul 14, 2026 | Chai Discovery | Series C | $400M | Index Ventures |
| Sep 22, 2026 | Heidi Health | Series C | $340M | Blackbird Ventures |
| Jun 25, 2026 | Ollin Biosciences | Series B | $330M | TCG Crossover |
| Sep 23, 2026 | Enveda Biosciences | Series E | $311M | Catalio Capital Management |
| Nov 19, 2025 | Function Health | Series B | $298M | Redpoint Ventures |
| Sep 16, 2026 | Anew Labs | — | $290M | HongShan (Sequoia China) |
| Sep 9, 2026 | Encoded Therapeutics | Series F | $275M | Google Ventures (GV) |
| Sep 25, 2026 | OpenEvidence | Series C | $250M | Andreessen Horowitz |
| Sep 24, 2026 | Precision Neuroscience | Series D | $250M | Pershing Square, Ackman Oxman Institute |
| Date | Company | Stage | Amount | Led by |
|---|---|---|---|---|
| Oct 8, 2026 | AblePay Health | Series A | $20M | F-Prime Capital |
| Oct 7, 2026 | Healthleap | Seed + Series A | $38M | Sequoia Capital, First Round Capital |
| Oct 7, 2026 | Healthleap | Series A | $38M | Sequoia Capital |
| Oct 7, 2026 | WhiteLab Genomics | Series B | $26M | — |
| Oct 6, 2026 | General Medicine | Series B | $120M | Andreessen Horowitz |
| Oct 6, 2026 | KymaThera | Series B | $80M | — |
| Oct 6, 2026 | Multiply Labs | Series B | $75M | — |
| Oct 6, 2026 | NorthStar Medical Technologies | Growth | $185M | — |
| Oct 6, 2026 | Vitalize | Series A | $31M | — |
| Sep 30, 2026 | Tiny Health | Series B | $33M | B Capital |
| Sep 29, 2026 | BioStem Technologies | — | $3M | — |
| Sep 25, 2026 | OpenEvidence | Series C | $250M | Andreessen Horowitz |